These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 6132473)

  • 21. [Salazosulfapyridine: old and new therapy concepts in inflammatory bowel diseases].
    Allgayer H; Kruis W
    Dtsch Med Wochenschr; 1985 Nov; 110(47):1827-9. PubMed ID: 2866083
    [No Abstract]   [Full Text] [Related]  

  • 22. The drug therapy of ulcerative colitis and of Crohn's disease.
    Tumen HJ
    Semin Drug Treat; 1974; 3(4):339-49. PubMed ID: 4150770
    [No Abstract]   [Full Text] [Related]  

  • 23. [Therapeutic trials in Crohn's disease and ulcerative colitis: ethics, objectives and methodology. A G.R.E.C. cooperative study].
    Hecketsweiler P; Bernier JJ; Geffroy Y
    Gastroenterol Clin Biol; 1979 Jan; 3(1):67-72. PubMed ID: 35438
    [No Abstract]   [Full Text] [Related]  

  • 24. Therapeutic efficacy of sulfasalazine and its metabolites in patients with ulcerative colitis and Crohn's disease.
    Klotz U; Maier K; Fischer C; Heinkel K
    N Engl J Med; 1980 Dec; 303(26):1499-502. PubMed ID: 6107853
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Pulmonary diffusing capacity disorder in nonspecific intestinal inflammations unexplainable by acetylation phenotype or treatment with sulfasalazine].
    Bures J; Horácek J; Tilser P; Fixa B; Komárková O; Tichý M; Zaydlar K; Král B
    Cas Lek Cesk; 1986 Jul; 125(29):905-9. PubMed ID: 2873894
    [No Abstract]   [Full Text] [Related]  

  • 26. Metronidazole in Crohn's disease.
    Gilat T
    Gastroenterology; 1982 Sep; 83(3):702-4. PubMed ID: 6124478
    [No Abstract]   [Full Text] [Related]  

  • 27. The thyroid in ulcerative colitis and Crohn's disease. I. Thyroid radioiodide uptake and urinary iodine excretion.
    Järnerot G
    Acta Med Scand; 1975; 197(1-2):77-81. PubMed ID: 235826
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Therapeutical experiments in ulcerative colitis and Crohn's disease.
    Nagy G; Prónay G; Ujszászy L
    Acta Med Hung; 1985; 42(3-4):163-74. PubMed ID: 2869469
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Mode of action of sulfasalazine in chronic inflammatory enterocolonic diseases].
    Delboy H
    Therapie; 1992; 47(2):157-9. PubMed ID: 1357770
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Drug treatment and formation of eicosanoids in patients with chronic inflammatory bowel disease.
    Lauritsen K
    Dan Med Bull; 1989 Sep; 36(4):378-93. PubMed ID: 2572403
    [No Abstract]   [Full Text] [Related]  

  • 31. The use of sulfasalazine in the treatment of inflammatory bowel disease.
    Spector R
    J Iowa Med Soc; 1983 Jun; 73(6):230-4. PubMed ID: 6135735
    [No Abstract]   [Full Text] [Related]  

  • 32. Letter: Value of uncontrolled trials in use of sulfasalazine.
    Goldstein F
    N Engl J Med; 1975 Aug; 293(9):455. PubMed ID: 239348
    [No Abstract]   [Full Text] [Related]  

  • 33. Pharmacokinetic patterns of sulfasalazine.
    Eastwood MA
    Ther Drug Monit; 1980; 2(2):149-52. PubMed ID: 6132472
    [No Abstract]   [Full Text] [Related]  

  • 34. [Significance of free oxygen radicals for pathogenesis of chronic inflammatory disease].
    Nielsen OH; Ahnfelt-Rønne I
    Ugeskr Laeger; 1992 Sep; 154(38):2544-6. PubMed ID: 1357806
    [No Abstract]   [Full Text] [Related]  

  • 35. The role of the colon in the metabolism of salicylazosulphapyridine.
    Das KM; Eastwood MA; McManus JP; Sircus W
    Scand J Gastroenterol; 1974; 9(2):137-41. PubMed ID: 4150441
    [No Abstract]   [Full Text] [Related]  

  • 36. Sulfasalazine. Pharmacology, clinical use, toxicity, and related new drug development.
    Peppercorn MA
    Ann Intern Med; 1984 Sep; 101(3):377-86. PubMed ID: 6147110
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Absorption of delayed-release prednisolone in ulcerative colitis and Crohn's disease.
    Thomas P; Richards D; Richards A; Rogers L; Evans BK; Dew MJ; Rhodes J
    J Pharm Pharmacol; 1985 Oct; 37(10):757-8. PubMed ID: 2867153
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Oral 5-aminosalicylic acid preparations in treatment of inflammatory bowel disease. An update.
    Martin F
    Dig Dis Sci; 1987 Dec; 32(12 Suppl):57S-63S. PubMed ID: 2891469
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Sulfasalazine therapy in inflammatory bowel disease.
    Das KM
    Gastroenterol Clin North Am; 1989 Mar; 18(1):1-20. PubMed ID: 2563989
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Drug information. Pentasa--new Danish drug].
    Dahlerup J
    Sygeplejersken; 1988 Jul; 88(28):16. PubMed ID: 2902698
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.